Eli Lilly and Company (LLY)

Jan 17, 2025, 6:45 PM EST - 4 hours ago

Dr. Kavita Patel talks impact of GLP-1 price negotiations

NVO

Jan 17, 2025, 11:55 AM EST - 11 hours ago

Ozempic, Wegovy among drugs subject to Medicare price controls

NVO

Jan 15, 2025, 4:24 PM EST - 2 days ago

US FDA approves expanded use of Lilly's bowel disease drug

Jan 15, 2025, 4:06 PM EST - 2 days ago

FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease

Jan 15, 2025, 3:18 PM EST - 2 days ago

Eli Lilly: Big 2025 Ahead, But Execution Risks Exist

Jan 15, 2025, 3:11 PM EST - 2 days ago

Eli Lilly cuts Q4 sales forecast, but analyst remains bullish on stock—here's why

Jan 15, 2025, 2:21 PM EST - 2 days ago

Eli Lilly Adjusts Outlook, CEO David Ricks Explains Revenue Shortfall

Jan 15, 2025, 8:25 AM EST - 2 days ago

Buy, Sell, Or Hold LLY Stock At $750?

Jan 14, 2025, 10:35 PM EST - 3 days ago

Watch These Eli Lilly Price Levels as Stock Slumps on Tepid Sales Outlook

Jan 14, 2025, 7:58 PM EST - 3 days ago

Eli Lilly and Company (LLY) CEO Dave Ricks presents at 43rd Annual J.P. Morgan Healthcare Conference (Transcript)

Jan 14, 2025, 7:52 PM EST - 3 days ago

Long-term possibilities in healthcare are unbelievable, says Jim Cramer

ABT CAH MRK REGN

Jan 14, 2025, 6:57 PM EST - 3 days ago

Jim Cramer says he supports healthcare stocks for their long-term value

MRK REGN

Jan 14, 2025, 5:51 PM EST - 3 days ago

Buy the weakness in Eli Lilly, says Mizuho Healthcare Strategist Jared Holz

Jan 14, 2025, 5:20 PM EST - 3 days ago

S&P 500 Gains and Losses Today: Eli Lilly Stock Falls as Sales Outlook Weakens

Jan 14, 2025, 4:31 PM EST - 3 days ago

Healthy Returns: From Eli Lilly to Amazon, here are the latest health-care deals

AMZN DXCM GSK JNJ MRNA NVDA TDOC

Jan 14, 2025, 4:07 PM EST - 3 days ago

Stock Market Today: Stocks Are Mixed Ahead of CPI

Jan 14, 2025, 2:20 PM EST - 3 days ago

Eli Lilly Stock Slumps on Lowered Sales Forecast

Jan 14, 2025, 1:40 PM EST - 3 days ago

Final Trades: Reddit, Delta, Thermo Fisher and Eli Lilly

RDDT TMO DAL

Jan 14, 2025, 12:45 PM EST - 3 days ago

Eli Lilly CEO on prospect of insurance companies covering weight loss drugs

Jan 14, 2025, 10:53 AM EST - 3 days ago

Eli Lily cuts 2024 revenue guidance by $400M, shares sink 8%

Jan 14, 2025, 10:46 AM EST - 3 days ago

Lilly's Zepbound and Mounjaro Sales Miss Estimates Again. The Wobble's Looking Serious.

Jan 14, 2025, 10:40 AM EST - 3 days ago

Eli Lilly Cuts Sales Outlook After Sluggish Growth for Incretin Drugs

Jan 14, 2025, 10:28 AM EST - 3 days ago

Eli Lilly CEO David Ricks: Projecting 32% total growth for company in 2025

Jan 14, 2025, 10:22 AM EST - 3 days ago

Cramer's Mad Dash: Eli Lilly

Jan 14, 2025, 10:20 AM EST - 3 days ago

Eli Lilly shares drop as drugmaker cuts revenue guidance on weight loss drug demand

Jan 14, 2025, 10:20 AM EST - 3 days ago

Mounjaro and Zepbound sales disappoint, and Eli Lilly's stock is dropping

Jan 14, 2025, 10:11 AM EST - 3 days ago

Eli Lilly Cuts Q4 Revenue Guidance, Expects Around $5.5 Billion Sales From Weight Loss/Diabetes Drugs, Stock Tanks

Jan 14, 2025, 9:33 AM EST - 3 days ago

Lilly forecasts weak sales of weight-loss drug in fourth quarter

Jan 14, 2025, 9:00 AM EST - 3 days ago

Lilly provides update on 2024 revenue guidance, announces 2025 revenue guidance

Jan 13, 2025, 8:00 PM EST - 4 days ago

Healthcare sector poised for rebound in 2025

GSK JNJ XLV

Jan 13, 2025, 6:10 PM EST - 4 days ago

Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025

ABBV AMGN AZN BNTX FBCG GILD GSK

Jan 13, 2025, 5:54 PM EST - 4 days ago

Eli Lilly CEO on Fighting Cancer and Obesity, Drug Pricing (Correct)

Jan 13, 2025, 1:30 PM EST - 4 days ago

Lilly asks US government to pause drug price negotiation program, Bloomberg News reports

Jan 13, 2025, 12:28 PM EST - 4 days ago

Eli Lilly CEO expects new weight loss pill to be approved next year

Jan 13, 2025, 12:07 PM EST - 4 days ago

Drugmakers rush to sign deals on first day of industry conference

ABBV GSK ITCI JNJ

Jan 13, 2025, 10:54 AM EST - 4 days ago

Eli Lilly CEO on Fighting Cancer and Obesity, Drug Pricing

Jan 13, 2025, 9:10 AM EST - 4 days ago

Eli Lilly to buy cancer drug developer Scorpion Therapeutics for $2.5 bln

Jan 13, 2025, 9:00 AM EST - 4 days ago

Lilly to acquire Scorpion Therapeutics' mutant-selective PI3Kα inhibitor program

Jan 13, 2025, 5:05 AM EST - 4 days ago

Lilly sues two medical spas over copycat weight-loss drugs

Jan 11, 2025, 4:46 AM EST - 6 days ago

Eli Lilly: Still Much Room To Ride The Weight-Loss Wave

Jan 10, 2025, 11:32 AM EST - 7 days ago

Andreessen Horowitz, Eli Lilly to launch $500 million venture fund

Jan 10, 2025, 11:08 AM EST - 7 days ago

High-cost weight loss drugs are sending employers to nutrition counseling in a boost for startups

CI

Jan 10, 2025, 8:48 AM EST - 7 days ago

Andreessen Horowitz Partners with Lilly to Launch First-of-Its-Kind Biotech Ecosystem Venture Fund

Jan 9, 2025, 4:10 PM EST - 8 days ago

Eli Lilly's Zepbound Can Now Be Covered by Medicare to Treat Sleep Apnea

Jan 9, 2025, 11:01 AM EST - 8 days ago

Medicare can cover Zepbound for sleep apnea, creating a significant opportunity for Eli Lilly

Jan 9, 2025, 7:27 AM EST - 8 days ago

Flynn: Eli Lilly could capture a significant part of a $100 billion market with Zepbound.

Jan 8, 2025, 3:46 PM EST - 9 days ago

Eli Lilly's obesity drug gets Medicare coverage for sleep apnea, CNBC reports

Jan 8, 2025, 3:17 PM EST - 9 days ago

Medicare can now cover Eli Lilly's Zepbound for sleep apnea, CMS says

Jan 8, 2025, 11:13 AM EST - 9 days ago

Healthy Returns: The FDA approved fewer new drugs in 2024 — but some big ones hit the market

AMGN BBIO BMY IOVA MDGL MRK PFE

Jan 7, 2025, 10:00 AM EST - 10 days ago

Lilly to participate in J.P. Morgan Healthcare Conference